Keywords: Contrast Agents, Contrast Agents, CD4+ T cells, Microbeads, immunomodulation, transplantation
Motivation: This study aims to address the challenge of in vivo tracking of CD4+ T-cells by MRI, focusing on biodistribution monitoring in adoptive cell therapies.
Goal(s): To develop and optimize a receptor-mediated labeling method of CD4+ T-cells with CD4-microbeads that enables in vivo MRI tracking.
Approach: CD4+ T-cells were labeled with CD4-microbeads; internalization and signal attenuation were analyzed via Iron staining, electron microscopy, and MRI. Microbead-labeled cells were injected intravenously, followed by longitudinal MRI tracking and histological analyses.
Results: Internalized CD4-microbeads in T-cells resulted in significant MRI signal reduction, and confirmed the feasibility of tracking labeled T-cells in liver tissue up to 72-hours post-injection.
Impact: The CD4-targeted microbead approach to track CD4+ T cells in vivo with MRI is safe, specific and sensitive. This technique will allow rapid assessment of the efficacy of adoptive cell therapies in conditions such as transplantation and diabetes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords